Loading...
Please wait, while we are loading the content...
Similar Documents
Budget Impact Analysis Of High-Risk Hpv Dna (Hrhpv) Test With 16/18 Genotyping As A Primary Screening Method For Cervical Cancer In Greece.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Skroumpelos, Anastasios Agorastos, Theodoros Chatzistamatiou, Kimon Akalestos, T. Poulios, Nick Kyriopoulos, John |
| Copyright Year | 2015 |
| Abstract | primary screening method for cervical cancer in Greece Skroumpelos A.1, Agorastos T.2, Chatzistamatiou K.2, Akalestos T.3, Poulios N.4, Kyriopoulos J.5 1Roche Pharmaceuticals, Athens, Greece 2Medical School, Aristotle University, Thessaloniki, Greece 3Roche Diagnostics, Athens, Greece 4Roche Molecular Diagnostics, Pleasanton, USA 5Department of Health Economics, National School of Public Health, Athens, Greece Background |
| File Format | PDF HTM / HTML |
| DOI | 10.1016/j.jval.2015.09.631 |
| PubMed reference number | 26531974 |
| Journal | Medline |
| Volume Number | 18 |
| Issue Number | 7 |
| Alternate Webpage(s) | https://www.ispor.org/research_pdfs/51/pdffiles/PMD30.pdf |
| Alternate Webpage(s) | https://doi.org/10.1016/j.jval.2015.09.631 |
| Journal | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |